Abstract
Background: The World Health Organization (WHO) declared tuberculosis (TB) a global public health emergency in 1993. It is the second leading cause of death from an infectious disease worldwide and leading cause of ill- health among millions of people. Treatment options of tuberculosis include intermittent therapy in DOTS and daily therapy. Aim of our study is to compare daily versus intermittent antituberculous treatment.
Methods: This observational prospective study was conducted at Indira Gandhi Medical College, Shimla. Detailed information was collected on predesigned proformas and results were compiled and evaluated on master chart.
Results: 460 children were diagnosed with various forms of tuberculosis, out of which 82 children fulfilling the inclusion criteria were enrolled in this study. These were divided into two groups (Group 1 and Group 2). The mean age at the time of enrollment was 10.34 years 42 (53.16%) were males and 37 (46.83%) females, with a sex ratio of M:F=1.1:1. sputum negativity in the daily therapy group showed statistical significance with a p value of < .05, an odds ratio of 0.17 with Confidence Intervals : 0.02 – 0.94.
Conclusion: Tuberculosis remains a major cause of mortality and morbidity in Pediatric population. Daily therapy may be a futuristic treatment option with better results.
Keywords: Tuberculosis Pediatric, Daily, Intermittent, Gastric aspirate.
References
- Dias Hannah Monica, Falzon Dennis. Global tuberculosis Report 2012, World Health Organization, 2012 (WHO/HTM/ STB/2012.
- Global tuberculosis control—epidemiology, strategy, financing. WHO Report 2014 http://www.who.int/tb/publications/global_report/2014/en/index.html. Accessed 31 May 2014.
- Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization.Tubercle 1991; 72:1–6.
- Raviglione M C, Snider D E, Kochi A. Global epidemiology of tuberculosis. JAMA 1995; 273:220–226.
- Munoz Flor M, Starke Jeffery R 213.Nelson 19th edition ;Elisevier: 960 61
- Chadha VK, Kumar P, Jagannatha PS, Vaidyanathan PS, Unnikrishnan KP. Average annual risk of tuberculous infection in India.Int J Tuberc Lung Dis 2005; 9(1):116-8.
- RNTCP new pediatric guidelines 2012 National Guidelines on diagnosis and treatment of Pediatric Tuberculosis.
- Kansoy S, Kurta N, Ak ít S, Aksoylar S, Yaprak I, Çalayan S. Superiority of intermittent-short course chemotherapy in childhood pulmonary tuberculosis. Turkish Journal of Medical Sciences1996; 26(1):41–3.
- Sarin R, Sharma S, Khalid U.K, et al. The DOTS strategy for treatment of pediatric pulmonary tuberculosis in South Delhi, India. Int J Tuberc Lung Dis; 11(12): 74-80.
- Naude Te Water, Donald PR, Hussey GD, Kibel MA, Louw A, Perkins DR, et al. Twice- weekly vs daily chemotherapy for childhood TB. Pediatr Infect Dis J 2000; 19:405-410.
- Göçmen A, Özçelic U, Kiper M, et al. Short course intermittent chemotherapy in childhood tuberculosis. Infection 1993; 21: 324-327.
- Al-Dossary FS, Ong LT, Correa AG, Starke JR. Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy. Pediatr Infect Dis J 2002; 21:91-97.
- Salih M, Eltayeb I, Zaki A, et al. Intermittent chemotherapy compared to the daily regimen in Sudanese patients with pulmonary tuberculosis. Time Journal of Medical Sciences Report and Research; 1(3): 2013.
- Prasad R, Rizavi D M, Kant S, et al. A comparison of unsupervised treatment along with intensive health education and directly observed treatment in pulmonary tuberculosis. Ind.J. Tub, 2001; 48,21.
- Qayyum S, Ahmed, Ansari G. Comparing daily versus partially intermittent regimen of ATT in non HIV patients with new pulmonary tuberculosis in Dots programme: OJHA Institute of Chest Diseases, Karachi.
- Mandal P, Mandal A,et al. comparing daily versus intermittent regimens of anti-tubercular chemotherapy. Journal of Clinical and Diagnostic Research,2012.
- Anil K Kashyap, Jagdeep Whig, Dinesh Gupta, Smiley Joshi. Clinical outcome of patients of tuberculosis under directly observed treatment short course in a tertiary care centre in Ludhiana India; Chest: Nov 3,2009.
- Kumar L, Dhand R, Singhi PD, Rao KL, Katarriya S. A randomized trial of fully intermittent and daily followed by intermittent short-course chemotherapy for childhood tuberculosis. Pediatr Infect ds J 1990; 9:802-806.
- Ramachandran P, Kripasankar A S, Duraipandian M. Shortcourse chemotherapy for pulmonary tuberculosis in children. Indian Journal of Tuberculosis 1998; 45:83-7.
- Indumati C K, Prasanna K, Dinakar C, et al. Intermittent short course therapy for pediatric tuberculosis. Indian Pediatrics; Vol 47, Jan: 2010.
- Diga R, Dalisay C. Comparison of modified directly observed therapy versus conventional treatment for active pulmonary tuberculosis. Phil Journal of Chest Diseases; 12(1):1-6.
- Mehrotra ML. Agra study of short course chemotherapy in pulmonary tuberculous patients: Ind J Tub.1982; 29:29-39.
- Singapore Tuberculosis Service, BMR Council. Long term follow up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133: 779–783.8.
- Hong Kong Chest Service/BMR Council. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide: Results at 30 months. Am Rev Respir Dis 1991;143: 700–706.
- Mohammad Taher, S K Sharma et al. DOTS at a tertiary care centre in northern India: scenario challenges and next step in TB control. Ind J Med Res. 123, May 2006; 702-06.
Corresponding Author
Dr Ambika Sood
Address: 98, Lower Bazaar, Shimla. Pin-171001, India
DOI: https://dx.doi.org/10.18535/jmscr/v7i8.104
